Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de James Patrick Tursi
Age : 57
Public asset : 833 USD
Linked companies : Endo International plc
Summary 
Currently, James Patrick Tursi holds the position of Executive VP-Global Research & Development at Endo International Plc.

He is also on the board of Ideal Image Development (Delaware), Inc. and Ideal Image Development Corp.

In his past career Dr. Tursi was Chief Medical Officer for Aralez Pharmaceuticals, Inc. and Chief Medical Officer for POZEN, Inc. (a subsidiary of Aralez Pharmaceuticals, Inc.), Chief Medical Officer & Executive Vice President at Antares Pharma, Inc., Chief Medical Officer for Auxilium Pharmaceuticals LLC, Director-Medical Affairs at GlaxoSmithKline Biologicals SA, Senior Medical Director-Medical Affairs at Procter & Gamble Pharmaceuticals, Inc., Chief Medical Officer at Innocoll Pharmaceuticals Ltd. and Chief Medical Officer for Innocoll AG.

James Patrick Tursi received an undergraduate degree from Drexel University College of Medicine and an undergraduate degree from Ursinus College.


Current positions of James Patrick Tursi 
NameTitle Since
Endo International plc
(Pharmaceuticals)
Executive VP-Global Research & Development 2022
Ideal Image Development (Delaware), Inc. Director 2021
Ideal Image Development Corp. Director 2021


James Patrick Tursi: Personal Network 
Most Read News 
01/25Musk says China rivals 'work hardest, smartest'
RE
01/26LVMH's Arnault brushes off succession question
RE
01/27Wood's ARK Innovation Fund on pace for best month ever as battered stocks surge
RE
01/19Ark's Wood remains bullish on Tesla, says oil stock rally 'defying logic'
RE
01/26Bill Ackman says Hindenburg's report on Adani Group 'highly credible'
RE
01/19JPMorgan CEO Dimon sees interest rates going beyond 5% - CNBC
RE
01/23Musk to return to stand in fraud trial over 2018 Tesla tweet
RE
01/19Sacked GM workers in India sue company, CEO Barra for unpaid compensation
RE
01/20Musk expected to take stand as trial resumes over Tesla tweet
RE
01/26Wells Fargo CEO Scharf's 2022 pay unchanged at $24.5 million
RE
More news


© 2023 People and Ownership :   
James Patrick Tursi : Connections